|
1
|
Davidoff AM: Neuroblastoma. Semin Pediatr
Surg. 21:2–14. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stafman LL and Beierle EA: Cell
proliferation in neuroblastoma. Cancers (Basel). 8:E132016.
View Article : Google Scholar
|
|
3
|
Esiashvili N, Anderson C and Katzenstein
HM: Neuroblastoma. Curr Probl Cancer. 33:333–360. 2009. View Article : Google Scholar
|
|
4
|
Colon NC and Chung DH: Neuroblastoma. Adv
Pediatr. 58:297–311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brodeur GM and Nakagawara A: Molecular
basis of clinical heterogeneity in neuroblastoma. Am J Pediatr
Hematol Oncol. 14:111–116. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bottino C, Dondero A, Bellora F, Moretta
L, Locatelli F, Pistoia V, Moretta A and Castriconi R: Natural
killer cells and neuroblastoma: tumor recognition, escape
mechanisms, and possible novel immunotherapeutic approaches. Front
Immunol. 5:562014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zimmerman KA, Yancopoulos GD, Collum RG,
Smith RK, Kohl NE, Denis KA, Nau MM, Witte ON, Toran-Allerand D,
Gee CE, et al: Differential expression of myc family genes during
murine development. Nature. 319:780–783. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang LL, Teshiba R, Ikegaki N, Tang XX,
Naranjo A, London WB, Hogarty MD, Gastier-Foster JM, Look AT, Park
JR, et al: Augmented expression of MYC and/or MYCN protein defines
highly aggressive MYC-driven neuroblastoma: A Children’s Oncology
Group study. Br J Cancer. 113:57–63. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schäfer MK and Altevogt P: L1CAM
malfunction in the nervous system and human carcinomas. Cell Mol
Life Sci. 67:2425–2437. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kiefel H, Bondong S, Hazin J, Ridinger J,
Schirmer U, Riedle S and Altevogt P: L1CAM: A major driver for
tumor cell invasion and motility. Cell Adhes Migr. 6:374–384. 2012.
View Article : Google Scholar
|
|
11
|
Poplawski GH, Tranziska AK, Leshchyns’ka
I, Meier ID, Streichert T, Sytnyk V and Schachner M: L1CAM
increases MAP2 expression via the MAPK pathway to promote neurite
outgrowth. Mol Cell Neurosci. 50:169–178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakata A and Kamiguchi H: Serine
phosphorylation by casein kinase II controls endocytic L1
trafficking and axon growth. J Neurosci Res. 85:723–734. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lewandowski G and Steward O:
AAVshRNA-mediated suppression of PTEN in adult rats in combination
with salmon fibrin administration enables regenerative growth of
corticospinal axons and enhances recovery of voluntary motor
function after cervical spinal cord injury. J Neurosci.
34:9951–9962. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schapira AH, Olanow CW, Greenamyre JT and
Bezard E: Slowing of neurodegeneration in Parkinson’s disease and
Huntington’s disease: Future therapeutic perspectives. Lancet.
384:545–555. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y and Schachner M: The intracellular
domain of L1CAM binds to casein kinase 2α and is neuroprotective
via inhibition of the tumor suppressors PTEN and p53. J Neurochem.
133:828–843. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Colombo F and Meldolesi J: L1-CAM and
N-CAM: From adhesion proteins to pharmacological targets. Trends
Pharmacol Sci. 36:769–781. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Friedli A, Fischer E, Novak-Hofer I, Cohrs
S, Ballmer-Hofer K, Schubiger PA, Schibli R and Grünberg J: The
soluble form of the cancer-associated L1 cell adhesion molecule is
a pro-angiogenic factor. Int J Biochem Cell Biol. 41:1572–1580.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schröder C, Schumacher U, Fogel M,
Feuerhake F, Müller V, Wirtz RM, Altevogt P, Krenkel S, Jänicke F
and Milde-Langosch K: Expression and prognostic value of L1-CAM in
breast cancer. Oncol Rep. 22:1109–1117. 2009.PubMed/NCBI
|
|
19
|
Son YS, Seong RH, Ryu CJ, Cho YS, Bae KH,
Chung SJ, Lee B, Min JK and Hong HJ: Brief report: L1 cell adhesion
molecule, a novel surface molecule of human embryonic stem cells,
is essential for self-renewal and pluripotency. Stem Cells.
29:2094–2099. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bao S, Wu Q, Li Z, Sathornsumetee S, Wang
H, McLendon RE, Hjelmeland AB and Rich JN: Targeting cancer stem
cells through L1CAM suppresses glioma growth. Cancer Res.
68:6043–6048. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wachowiak R, Fiegel HC, Kaifi JT, Quaas A,
Krickhahn A, Schurr PG, Erttmann R, Schachner M, Kluth D, Sauter G,
et al: L1 is associated with favorable outcome in neuroblastomas in
contrast to adult tumors. Ann Surg Oncol. 14:3575–3580. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chong Y, Zhang J, Guo X, Li G, Zhang S, Li
C, Jiao Z and Shao M: MicroRNA-503 acts as a tumor suppressor in
osteosarcoma by targeting L1CAM. PLoS One. 9:e1145852014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weiswald LB, Bellet D and Dangles-Marie V:
Spherical cancer models in tumor biology. Neoplasia. 17:1–15. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mack SC, Hubert CG, Miller TE, Taylor MD
and Rich JN: An epigenetic gateway to brain tumor cell identity.
Nat Neurosci. 19:10–19. 2016. View
Article : Google Scholar
|
|
25
|
Xie Q, Flavahan WA, Bao S and Rich J: The
tailless root of glioma: cancer stem cells. Cell Stem Cell.
15:114–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chakrabarti L, Wang BD, Lee NH and Sandler
AD: A mechanism linking Id2-TGFβ crosstalk to reversible adaptive
plasticity in neuroblastoma. PLoS One. 8:e835212013. View Article : Google Scholar
|
|
27
|
Chakrabarti L, Abou-Antoun T, Vukmanovic S
and Sandler AD: Reversible adaptive plasticity: A mechanism for
neuroblastoma cell heterogeneity and chemo-resistance. Front Oncol.
2:822012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abouantoun TJ, Castellino RC and MacDonald
TJ: Sunitinib induces PTEN expression and inhibits PDGFR signaling
and migration of medulloblastoma cells. J Neurooncol. 101:215–226.
2011. View Article : Google Scholar
|
|
29
|
London WB, Castleberry RP, Matthay KK,
Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM,
Reynolds CP, et al: Evidence for an age cutoff greater than 365
days for neuroblastoma risk group stratification in the Children’s
Oncology Group. J Clin Oncol. 23:6459–6465. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bondong S, Kiefel H and Erbe-Hoffmann N:
Prognostic significance of L1CAM in ovarian cancer and its role in
constitutive NF-κB activation. Ann Oncol. 23:1795–1802. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li S, Jo YS, Lee JH, Min JK, Lee ES, Park
T, Kim JM and Hong HJ: L1 cell adhesion molecule is a novel
independent poor prognostic factor of extrahepatic
cholangiocarcinoma. Clin Cancer Res. 15:7345–7351. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hai J, Zhu CQ, Bandarchi B, Wang YH, Navab
R, Shepherd FA, Jurisica I and Tsao MS: L1 cell adhesion molecule
promotes tumorigenicity and metastatic potential in non-small cell
lung cancer. Clin Cancer Res. 18:1914–1924. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Linnemann D and Bock E: Expression of the
cell adhesion molecules N-CAM and L1 in B16 melanoma cells. Med
Biol. 64:345–349. 1986.PubMed/NCBI
|
|
34
|
Fogel M, Mechtersheimer S, Huszar M,
Smirnov A, Abu-Dahi A, Tilgen W, Reichrath J, Georg T, Altevogt P
and Gutwein P: L1 adhesion molecule (CD 171) in development and
progression of human malignant melanoma. Cancer Lett. 189:237–247.
2003. View Article : Google Scholar
|
|
35
|
Linnemann D, Raz A and Bock E:
Differential expression of cell adhesion molecules in variants of
K1735 melanoma cells differing in metastatic capacity. Int J
Cancer. 43:709–712. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thies A, Schachner M, Moll I, Berger J,
Schulze HJ, Brunner G and Schumacher U: Overexpression of the cell
adhesion molecule L1 is associated with metastasis in cutaneous
malignant melanoma. Eur J Cancer. 38:1708–1716. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dillon LM and Miller TW: Therapeutic
targeting of cancers with loss of PTEN function. Curr Drug Targets.
15:65–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gavert N, Sheffer M, Raveh S, Spaderna S,
Shtutman M, Brabletz T, Barany F, Paty P, Notterman D, Domany E, et
al: Expression of L1-CAM and ADAM10 in human colon cancer cells
induces metastasis. Cancer Res. 67:7703–7712. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Boo YJ, Park JM, Kim J, Chae YS, Min BW,
Um JW and Moon HY: L1 expression as a marker for poor prognosis,
tumor progression, and short survival in patients with colorectal
cancer. Ann Surg Oncol. 14:1703–1711. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kaifi JT, Reichelt U, Quaas A, Schurr PG,
Wachowiak R, Yekebas EF, Strate T, Schneider C, Pantel K, Schachner
M, et al: L1 is associated with micrometastatic spread and poor
outcome in colorectal cancer. Mod Pathol. 20:1183–1190. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ben Q, An W, Fei J, Xu M, Li G, Li Z and
Yuan Y: Downregulation of L1CAM inhibits proliferation, invasion
and arrests cell cycle progression in pancreatic cancer cells in
vitro. Exp Ther Med. 7:785–790. 2014.PubMed/NCBI
|
|
42
|
Raveh S, Gavert N and Ben-Ze’ev A: L1 cell
adhesion molecule (L1CAM) in invasive tumors. Cancer Lett.
282:137–145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Keerthikumar S, Gangoda L, Liem M, Fonseka
P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS and
Mathivanan S: Proteogenomic analysis reveals exosomes are more
oncogenic than ectosomes. Oncotarget. 6:15375–15396. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cheng L, Wu Q, Huang Z, Guryanova OA,
Huang Q, Shou W, Rich JN and Bao S: L1CAM regulates DNA damage
checkpoint response of glioblastoma stem cells through NBS1. EMBO
J. 30:800–813. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schaefer AW, Kamiguchi H, Wong EV, Beach
CM, Landreth G and Lemmon V: Activation of the MAPK signal cascade
by the neural cell adhesion molecule L1 requires L1
internalization. J Biol Chem. 274:37965–37973. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cheng L, Lemmon S and Lemmon V: RanBPM is
an L1-interacting protein that regulates L1-mediated
mitogen-activated protein kinase activation. J Neurochem.
94:1102–1110. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zecchini S, Bianchi M, Colombo N, Fasani
R, Goisis G, Casadio C, Viale G, Liu J, Herlyn M, Godwin AK, et al:
The differential role of L1 in ovarian carcinoma and normal ovarian
surface epithelium. Cancer Res. 68:1110–1118. 2008. View Article : Google Scholar : PubMed/NCBI
|
